Volume | 450,246 |
|
|||||
News | - | ||||||
Day High | 0.148 | Low High |
|||||
Day Low | 0.1402 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Kraig Biocraft Laboratories Inc (QB) | KBLB | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.148 | 0.1402 | 0.148 | 0.1469 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
80 | 450,246 | US$ 0.144833 | US$ 65,211 | - | 0.025 - 0.15 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
13:17:18 | 5,600 | US$ 0.1402 | USD |
Kraig Biocraft Laboratories Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
144.67M | 1.03B | 594.49M | 0 | -3.03M | -0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Kraig Biocraft Laborator... (QB) News
Date | Time | Source | News Article |
---|---|---|---|
6/10/2024 | 15:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
6/03/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
11/22/2023 | 15:31 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
11/16/2023 | 15:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
11/13/2023 | 15:43 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
9/11/2023 | 15:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
9/01/2023 | 15:30 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
8/14/2023 | 15:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KBLB Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1335 | 0.148 | 0.1318 | 0.1401534 | 1,069,726 | 0.0067 | 5.02% |
1 Month | 0.1281 | 0.148 | 0.102 | 0.1273565 | 995,667 | 0.0121 | 9.45% |
3 Months | 0.0948 | 0.148 | 0.069865 | 0.1088184 | 1,221,994 | 0.0454 | 47.89% |
6 Months | 0.031 | 0.15 | 0.03 | 0.0910404 | 1,347,075 | 0.1092 | 352.26% |
1 Year | 0.0442 | 0.15 | 0.025 | 0.0769346 | 885,614 | 0.096 | 217.19% |
3 Years | 0.1201 | 0.15 | 0.025 | 0.0698378 | 1,080,843 | 0.0201 | 16.74% |
5 Years | 0.30 | 0.498 | 0.025 | 0.1382135 | 1,346,612 | -0.1598 | -53.27% |
Kraig Biocraft Laborator... (QB) Description
Kraig Biocraft Laboratories, Inc. is a biotechnology company focused on the development of high performance polymers. Our genetic engineering research has succeeded in developing what many considered to be the holy grail of material science: A practical, cost-effective, and eco-responsible technology for producing recombinant spider silk based fibers on an industrial scale. We are moving rapidly to commercialize our spider silk technology, which we believe will have a significant impact on the global textiles industry. At the same time we are continuing to work to create new stronger and more flexible spider silk based fibers with potentially broad applications for consumers and industry in the multi-billion dollar marketplace for textiles and performance polymers. At Kraig, we are passionate about pioneering the research, development and commercialization of the next generation of high performance fibers based on genetic engineered spider silk. |